• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

CBO Cuts Cost Estimate for Obama Healthcare Law

Article

Barack Obama

Congressional Budget Office

The estimated net costs of expanding healthcare coverage under President 's landmark restructuring have been reduced by $48 billion through 2021, though fewer people would be covered under private insurance plans, a new analysis from the nonpartisan showed on Tuesday.

The CBO also revised its overall federal budget deficit estimates to show a $92 billion increase in the projected fiscal gap for 2012, confirming a fourth straight year of $1 trillion-plus deficits.

Read the full story: http://hcp.lv/ApNq7O

Source: Chicago Tribune

Related Videos
Dr Guru Sonpavde
Video 2 - "Adverse Events & Existing Treatment Options for Dry Eye Disease"
Overview of Dry Eye Disease (DED) Causes and Treatments
Related Content
Black patient speaking with doctor | Image credit: Dragana Gordic - stock.adobe.com

Patients With Rheumatic Diseases Report Low Satisfaction After Mandatory Biosimilar Switch

December 1st 2023
Article

A mandatory nationwide transition from reference adalimumab to a biosimilar was implemented in New Zealand.

Read More

Managed Care Cost podcast logo on white background

Managed Care Cast Presents: Insights Into Precision Medicine in NSCLC

November 30th 2023
Podcast

In this podcast, a trio of experts discuss precision medicine in non–small cell lung cancer (NSCLC), current immunotherapies, and more.

Listen

Woman laying on bed with mobile phone, using medical app | Prostock-studio - stock.adobe.com

Smartphone-Based App Demonstrates Clinical Benefits in Fibromyalgia Management

December 1st 2023
Article

At 12 weeks, significantly more patients with fibromyalgia receiving the smartphone-based intervention reported clinical improvements compared with the control group.

Read More

Managed Care Cast Presents: Opportunities for Adalimumab Biosimilars, Part 2

Managed Care Cast Presents: Opportunities for Adalimumab Biosimilars, Part 2

November 21st 2023
Podcast

In part 2 of this 2-part podcast, a panel of experts discusses implementation biosimilars in biologic-naïve patients, auto-substitution, and more.

Listen

Global health | Image credit: bahtiarmaulana – stock.adobe.com

Review Highlights Variation in Pediatric T1D Incidence by Country, Age

December 1st 2023
Article

The highest incidence of pediatric type 1 diabetes (T1D) over the past 22 years was seen in Finland, high-income North American regions, and children aged 5 to 14 years.

Read More

Site Logo

Driving Public Health Goals: A Look at Successful Innovative Vaccination Initiatives

December 1st 2023
Article

Read More

© 2023 MJH Life Sciences
AJMC®
All rights reserved.